Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Bray

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Cell Biology|January 5, 2011
Su(dx) E3 ubiquitin ligase-dependent and -independent functions of polychaetoid, the Drosophila ZO-1 homologueAlexandre Djiane, Hideyuki Shimizu, Marian Wilkin, et al.
Perceptual and Motor Skills|June 10, 2016
The Psychometric Properties of a Modified Sit-to-Stand Test With Use of the Upper Extremities in Institutionalized Older AdultsMelanie Le Berre, David Apap, Jade Babcock, et al.
Journal of the American Heart Association|September 8, 2022
Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein CholesterolPeter P Toth, Sarah Bray, Guillermo Villa, et al.
The Lancet Regional Health. Europe|August 7, 2023
Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI studyJulia Brandts, Sarah Bray, Guillermo Villa, et al.
AIDS (London, England)|January 13, 2022
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension periodFranck Boccara, Bruno Caramelli, Alexandra Calmy, et al.
American Heart Journal|December 17, 2019
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristicsFranck Boccara, Princy Kumar, Bruno Caramelli, et al.
Development (Cambridge, England)|August 2, 2017
Genome-wide identification of Grainy head targets in <i>Drosophila</i> reveals regulatory interactions with the POU domain transcription factor VvlLiqun Yao, Shenqiu Wang, Jakub O Westholm, et al.
Journal of the American College of Cardiology|April 3, 2020
Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK StudyFranck Boccara, Princy N Kumar, Bruno Caramelli, et al.
Development (Cambridge, England)|December 31, 2009
Drosophila Hey is a target of Notch in asymmetric divisions during embryonic and larval neurogenesisMaria Monastirioti, Nikolaos Giagtzoglou, Konstantinos A Koumbanakis, et al.
RMD Open|October 6, 2025
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamideDuvuru Geetha, Thomas Neumann, Alexandre Karras, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Cell Biology|January 5, 2011
Su(dx) E3 ubiquitin ligase-dependent and -independent functions of polychaetoid, the Drosophila ZO-1 homologueAlexandre Djiane, Hideyuki Shimizu, Marian Wilkin, et al.
Perceptual and Motor Skills|June 10, 2016
The Psychometric Properties of a Modified Sit-to-Stand Test With Use of the Upper Extremities in Institutionalized Older AdultsMelanie Le Berre, David Apap, Jade Babcock, et al.
Journal of the American Heart Association|September 8, 2022
Network Meta-Analysis of Randomized Trials Evaluating the Comparative Efficacy of Lipid-Lowering Therapies Added to Maximally Tolerated Statins for the Reduction of Low-Density Lipoprotein CholesterolPeter P Toth, Sarah Bray, Guillermo Villa, et al.
The Lancet Regional Health. Europe|August 7, 2023
Optimal implementation of the 2019 ESC/EAS dyslipidaemia guidelines in patients with and without atherosclerotic cardiovascular disease across Europe: a simulation based on the DA VINCI studyJulia Brandts, Sarah Bray, Guillermo Villa, et al.
AIDS (London, England)|January 13, 2022
Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension periodFranck Boccara, Bruno Caramelli, Alexandra Calmy, et al.
American Heart Journal|December 17, 2019
Evolocumab treatment in patients with HIV and hypercholesterolemia/mixed dyslipidemia: BEIJERINCK study design and baseline characteristicsFranck Boccara, Princy Kumar, Bruno Caramelli, et al.
Development (Cambridge, England)|August 2, 2017
Genome-wide identification of Grainy head targets in <i>Drosophila</i> reveals regulatory interactions with the POU domain transcription factor VvlLiqun Yao, Shenqiu Wang, Jakub O Westholm, et al.
Journal of the American College of Cardiology|April 3, 2020
Evolocumab in HIV-Infected Patients With Dyslipidemia: Primary Results of the Randomized, Double-Blind BEIJERINCK StudyFranck Boccara, Princy N Kumar, Bruno Caramelli, et al.
Development (Cambridge, England)|December 31, 2009
Drosophila Hey is a target of Notch in asymmetric divisions during embryonic and larval neurogenesisMaria Monastirioti, Nikolaos Giagtzoglou, Konstantinos A Koumbanakis, et al.
RMD Open|October 6, 2025
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamideDuvuru Geetha, Thomas Neumann, Alexandre Karras, et al.
Pageof 6